Background evidence suggests GLP‐1RAs could have a protective role on beta‐cells, stimulating insulin secretion, possibly downregulating pancreatic autoimmunity, and ameliorating glucose control in the early treatment of T1D and in patients with reduced pancreatic reserve. This evidence concerns the gene INS and type 1 diabetes mellitus.